Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies
Andrea Necchi(Fondazione IRCCS Istituto Nazionale dei Tumori), Daniele Raggi(Fondazione IRCCS Istituto Nazionale dei Tumori), Andrea Gallina(San Raffaele University of Rome), Russell W. Madison(Foundation Medicine (United States)), Maurizio Colecchia(Fondazione IRCCS Istituto Nazionale dei Tumori), Roberta Lucianò(San Raffaele University of Rome), Rodolfo Montironi(Marche Polytechnic University), Patrizia Giannatempo(Fondazione IRCCS Istituto Nazionale dei Tumori), Elena Farè(Fondazione IRCCS Istituto Nazionale dei Tumori), Filippo Pederzoli(San Raffaele University of Rome), Marco Bandini(San Raffaele University of Rome), Marco Bianchi(San Raffaele University of Rome), Renzo Colombo(San Raffaele University of Rome), Giorgio Gandaglia(San Raffaele University of Rome), Nicola Fossati(San Raffaele University of Rome), Laura Marandino(Fondazione IRCCS Istituto Nazionale dei Tumori), Umberto Capitanio(San Raffaele University of Rome), Federico Dehò(San Raffaele University of Rome), Siraj M. Ali(Foundation Medicine (United States)), Jon Chung(Foundation Medicine (United States)), Jeffrey S. Ross(SUNY Upstate Medical University), Andrea Salonia(Vita-Salute San Raffaele University), Alberto Briganti(Vita-Salute San Raffaele University), Francesco Montorsi(Vita-Salute San Raffaele University)
Cited by 318
Abstract
Related Papers
No related papers found
Powered by citation graph analysis